DoctoRx Unscripted
DoctoRx Unscripted
Podcast Description
Welcome to DoctoRx Unscripted — where doctors shaping the next chapter of patient care come together for raw, real, and rigorously scientific conversations at the heart of medicine. Hosted by Dr. Tania Small, SVP of Global Medical Affairs — a physician who has dedicated her career to turning breakthrough science into real-world patient impact. In each episode, Dr. Small sits down with the world’s leading minds in medicine to dive into the breakthroughs, surface the unspoken realities, and tackle the real-world challenges shaping tomorrow’s standard of care.
No soundbites. No scripts.
Just evidence-based, peer-to-peer conversations that challenge thinking, ignite innovation, and equip you with insights to transform your own practice. So whether you’re in the clinic, the lab, or the boardroom — join us to rewrite patient care.
Unscripted. Unfiltered. Unapologetically.
Podcast Insights
Content Themes
The podcast focuses on various themes within medicine, including innovations in patient care, advancements in psychiatric treatment, and health equity challenges. For example, recent episodes cover topics such as Alzheimer's disease research, the complexities of forensic psychiatry, and the future of schizophrenia care, emphasizing evidence-based discussions that aim to reshape standards of care.
Welcome to DoctoRx Unscripted — where doctors shaping the next chapter of patient care come together for raw, real, and rigorously scientific conversations at the heart of medicine. Hosted by Dr. Tania Small, SVP of Global Medical Affairs — a physician who has dedicated her career to turning breakthrough science into real-world patient impact. In each episode, Dr. Small sits down with the world’s leading minds in medicine to dive into the breakthroughs, surface the unspoken realities, and tackle the real-world challenges shaping tomorrow’s standard of care.
No soundbites. No scripts.
Just evidence-based, peer-to-peer conversations that challenge thinking, ignite innovation, and equip you with insights to transform your own practice. So whether you’re in the clinic, the lab, or the boardroom — join us to rewrite patient care.
Unscripted. Unfiltered. Unapologetically.
Highlights include:
• Early detection and the potential of screening studies like PROMISE and iStopMM
• Modifiable risk factors—how diet, exercise, and inflammation shape disease and outcomes
• Emerging therapies on the horizon
• Why “down with dex” and other old beliefs deserve retirement
• The personal “why” behind every advance in myeloma care
About the Experts
Dr. Paul Richardson
Dr. Paul Richardson is an internationally recognized visionary in hematology and oncology whose trailblazing research at Dana-Farber Cancer Institute and Harvard Medical School has driven therapeutic revolutions in multiple myeloma, transforming patient outcomes and defining today’s standards of care. In addition to his involvement in the approval of nearly every major therapy for the disease over the past two decades, he is also one of the most prolific and cited experts in the field, with nearly 500 original articles and 400 reviews.
Dr. Richardson is a paid consultant for BMS.
Dr. Joseph Mikhael
Dr. Joseph Mikhael has revolutionized and broadened access to world-class myeloma care globally through his pioneering leadership at TGen and the International Myeloma Foundation and as principal investigator of numerous groundbreaking clinical trials, setting new benchmarks in innovation, impact, and equity. Celebrated as a dynamic champion for underserved communities, an award-winning educator, and a masterful communicator, Dr. Mikhael has authored over 150 influential scientific articles and was recently recognized among America’s Top 100 Doctors for his transformational contributions to the field.
Dr. Mikhael was not compensated for his participation.
Dr. Mecide Gharibo
Dr. Mecide Gharibo is an innovative hematology leader whose passion for transforming patient care extends from academic clinical expertise at Rutgers Cancer Institute to launching breakthrough therapies as Global Head of Hematology at Bristol Myers Squibb. Renowned for advancing life-saving treatments and optimizing patient access, Dr. Gharibo’s clinical excellence and senior pharmaceutical leadership have fueled medical innovation and set new standards for care through a proven record of successful therapy approvals.
Dr. Gharibo is an employee of BMS.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.